Fisher SD - Search Results

1

Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients.

Lipshultz SE, Fisher SD, Lai WW, Miller TL. Lipshultz SE, et al. Among authors: fisher sd. AIDS. 2003 Apr;17 Suppl 1:S96-122. doi: 10.1097/00002030-200304001-00014. AIDS. 2003. PMID: 12870537 Review.

2

Mediators in HIV-associated cardiovascular disease: a focus on cytokines and genes.

Fisher SD, Bowles NE, Towbin JA, Lipshultz SE. Fisher SD, et al. AIDS. 2003 Apr;17 Suppl 1:S29-35. doi: 10.1097/00002030-200304001-00005. AIDS. 2003. PMID: 12870528 Review.

3

Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America.

Lipshultz SE, Miller TL, Wilkinson JD, Scott GB, Somarriba G, Cochran TR, Fisher SD. Lipshultz SE, et al. Among authors: fisher sd. J Int AIDS Soc. 2013 Jun 18;16(1):18597. doi: 10.7448/IAS.16.1.18597. J Int AIDS Soc. 2013. PMID: 23782480 Free PMC article. Review.

4

Epidemiology of cardiovascular involvement in HIV disease and AIDS.

Fisher SD, Lipshultz SE. Fisher SD, et al. Ann N Y Acad Sci. 2001 Nov;946:13-22. doi: 10.1111/j.1749-6632.2001.tb03900.x. Ann N Y Acad Sci. 2001. PMID: 11762981 Review.

5

Cardiovascular monitoring and therapy for HIV-infected patients.

Lipshultz SE, Fisher SD, Lai WW, Miller TL. Lipshultz SE, et al. Among authors: fisher sd. Ann N Y Acad Sci. 2001 Nov;946:236-73. doi: 10.1111/j.1749-6632.2001.tb03916.x. Ann N Y Acad Sci. 2001. PMID: 11762991 Review.

6

Accelerated cardiovascular disease and myocardial infarction risk in patients with the human immunodeficiency virus.

Sharma TS, Messiah S, Fisher S, Miller TL, Lipshultz SE. Sharma TS, et al. J Cardiometab Syndr. 2008 Spring;3(2):93-7. doi: 10.1111/j.1559-4572.2008.07635.x. J Cardiometab Syndr. 2008. PMID: 18453809

7

Myocardial and Pericardial Disease in HIV.

Harmon WG, Dadlani GH, Fisher SD, Lipshultz SE. Harmon WG, et al. Among authors: fisher sd. Curr Treat Options Cardiovasc Med. 2002 Dec;4(6):497-509. doi: 10.1007/s11936-002-0043-z. Curr Treat Options Cardiovasc Med. 2002. PMID: 12408791

8

HIV-related cardiovascular disease and drug interactions.

Nanavati KA, Fisher SD, Miller TL, Lipshultz SE. Nanavati KA, et al. Among authors: fisher sd. Am J Cardiovasc Drugs. 2004;4(5):315-24. doi: 10.2165/00129784-200404050-00004. Am J Cardiovasc Drugs. 2004. PMID: 15449973 Review.

9

Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis.

Fisher SD, Miller TL, Lipshultz SE. Fisher SD, et al. Atherosclerosis. 2006 Mar;185(1):1-11. doi: 10.1016/j.atherosclerosis.2005.09.025. Epub 2005 Nov 16. Atherosclerosis. 2006. PMID: 16297390 Review.

10

Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients.

Fisher SD, Kanda BS, Miller TL, Lipshultz SE. Fisher SD, et al. Am J Cardiovasc Drugs. 2011 Dec 1;11(6):383-94. doi: 10.2165/11594590-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 22149317 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page